Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001999371-25-020336
Filing Date
2025-12-15
Accepted
2025-12-15 16:32:10
Documents
1
Period of Report
2025-12-11

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP gsk-form4_121225.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP gsk-form4_121225.xml 4 3484
  Complete submission text file 0001999371-25-020336.txt   5728
Mailing Address 79 NEW OXFORD STREET LONDON United Kingdom
Business Address 79 NEW OXFORD STREET LONDON United Kingdom 44 20 8047 5000
GSK plc (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 251572044
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)